Cargando…

Efficacy and safety of bexarotene combined with photo(chemo)therapy for cutaneous T‐cell lymphoma

Cutaneous T‐cell lymphoma (CTCL) is a chronic condition with low malignancy. International treatment guidelines for CTCL are widely followed in Europe and the USA. Combination therapy with therapeutic agents for CTCL and phototherapy is effective on the basis of European data. The efficacy and safet...

Descripción completa

Detalles Bibliográficos
Autores principales:	Morita, Akimichi, Tateishi, Chiharu, Muramatsu, Shinnosuke, Kubo, Ryouji, Yonezawa, Eri, Kato, Hiroshi, Nishida, Emi, Tsuruta, Daisuke
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7318242/ https://www.ncbi.nlm.nih.gov/pubmed/32189402 http://dx.doi.org/10.1111/1346-8138.15310

Ejemplares similares

Comparison of the Efficacy and Safety of Bexarotene and Photo(Chemo)Therapy Combination Therapy and Bexarotene Monotherapy for Cutaneous T-Cell Lymphoma
por: Morita, Akimichi, et al.
Publicado: (2022)

Photo(chemo)therapy Reduces Circulating Th17 Cells and Restores Circulating Regulatory T Cells in Psoriasis
por: Furuhashi, Takuya, et al.
Publicado: (2013)

Bexarotene Reduces Production of CCL22 From Tumor-Associated Macrophages in Cutaneous T-Cell Lymphoma
por: Tanita, Kayo, et al.
Publicado: (2019)

Development of Bexarotene Analogs for Treating Cutaneous T-Cell Lymphomas
por: Warda, Ankedo, et al.
Publicado: (2023)

Advanced-Stage Primary Cutaneous T-Cell Lymphoma Treated with Bexarotene and Denileukin Diftitox
por: Cervigón-González, Iván, et al.
Publicado: (2011)

Phase II study of gemcitabine and bexarotene (GEMBEX) in the treatment of cutaneous T-cell lymphoma
por: Illidge, T, et al.
Publicado: (2013)

Successful Treatment of Advanced Primary Cutaneous Peripheral T-Cell Lymphoma with Oral Bexarotene Monotherapy
por: Sato, Yota, et al.
Publicado: (2018)

Real-life Use of Bexarotene for T-cell Cutaneous Lymphoma Management: Efficacy and Tolerance with Low Doses
por: ROUANET, Jacques, et al.
Publicado: (2022)

CD25 expression could be a prognostic marker of bexarotene monotherapy for cutaneous T‐cell lymphomas
por: Yamamoto, Jun, et al.
Publicado: (2023)

Successful Treatment of a Panniculitis-Like Primary Cutaneous T-Cell Lymphoma of the α/β Type with Bexarotene
por: Zhang, X., et al.
Publicado: (2012)

Successful Treatment of Primary Cutaneous Peripheral T-Cell Lymphoma Presenting Acquired Ichthyosis with Oral Bexarotene Monotherapy
por: Tanita, Kayo, et al.
Publicado: (2017)

Efficacy of bath‐psoralen and ultraviolet A therapy for mycosis fungoides – retrospective analysis of 62 cases
por: Shintani, Yoichi, et al.
Publicado: (2021)

Cost-Effectiveness of Brentuximab Vedotin Versus Physician’s Choice of Methotrexate or Bexarotene for the Treatment of Cutaneous T-cell Lymphoma in Canada
por: Elsea, David, et al.
Publicado: (2023)

Time to next treatment and safety assessment in cutaneous‐T‐cell lymphomas: a retrospective analysis on patients treated with bexarotene and acitretin
por: Roccuzzo, Gabriele, et al.
Publicado: (2022)

Determining the immune environment of cutaneous T-cell lymphoma lesions through the assessment of lesional blood drops
por: Torii, Kan, et al.
Publicado: (2021)

Efficacy and safety of apremilast and phototherapy versus phototherapy only in psoriasis vulgaris
por: Morita, Akimichi, et al.
Publicado: (2022)

Paraneoplastic Pemphigus Mimicking Toxic Epidermal Necrolysis Associated with Follicular Lymphoma: Possible Pathological Role of CD8 T Cells
por: KOKUBU, Hiraku, et al.
Publicado: (2020)

Long‐term efficacy and safety of bexarotene for Japanese patients with cutaneous T‐cell lymphoma: The results of a phase 2 study (B‐1201)
por: Hamada, Toshihisa, et al.
Publicado: (2019)

A Novel Co-Crystal of Bexarotene and Ligustrazine Improves Pharmacokinetics and Tissue Distribution of Bexarotene in SD Rats
por: Ren, Shuyue, et al.
Publicado: (2020)

Photodegradation of Bexarotene and Its Implication for Cytotoxicity
por: Kryczyk-Poprawa, Agata, et al.
Publicado: (2021)

The utility of bexarotene in mycosis fungoides and Sézary syndrome
por: Panchal, Manisha R, et al.
Publicado: (2015)

Preclinical PET Neuroimaging of [(11)C]Bexarotene
por: Rotstein, Benjamin H., et al.
Publicado: (2016)

Bexarotene-Induced Hypertriglyceridemia: A Case Report
por: Maminakis, Chris, et al.
Publicado: (2018)

Two sporadic cases of childhood-onset Hailey-Hailey disease with superimposed mosaicism
por: Asahina, Yasuhiko, et al.
Publicado: (2023)

Dupilumab probably reduces transepidermal water loss but does not increase stratum corneum hydration in atopic dermatitis
por: Furuhashi, Takuya, et al.
Publicado: (2020)

Identification of Bexarotene as a PPARγ Antagonist with HDX
por: Marciano, David P., et al.
Publicado: (2015)

Bexarotene Gel: A New Topical Therapy for Alopecia Areata
por: Rajiv, Mahajan, et al.
Publicado: (2010)

The emerging role of bexarotene in the treatment of Alzheimer’s disease: current evidence
por: Tousi, Babak
Publicado: (2015)

Bexarotene: A Rare Cause of Misleading Thyroid Function Tests
por: Pattan, Vishwanath, et al.
Publicado: (2020)

Cocrystal Prediction of Bexarotene by Graph Convolution Network and Bioavailability Improvement
por: Xiao, Fu, et al.
Publicado: (2022)

FRI511 Bexarotene: A Deceptive Cause Of Iatrogenic Hypothyroidism
por: Ghaith, Sarah, et al.
Publicado: (2023)

Primary Cutaneous Gamma-Delta T-Cell Lymphoma Initially Diagnosed as Subcutaneous Panniculitis-like T-Cell Lymphoma with Dermatomyositis
por: Hirata, Chika, et al.
Publicado: (2022)

Early Treatment Critical: Bexarotene Reduces Amyloid-Beta Burden In Silico
por: Rosenthal, Joseph, et al.
Publicado: (2016)

Effectiveness of combined bexarotene and excimer laser treatment for folliculotropic mycosis fungoides
por: Furukawa, Fumina, et al.
Publicado: (2021)

High-Dose Thyroid Hormone Replacement in Bexarotene-Induced Central Hypothyroidism
por: Mathews, Tony, et al.
Publicado: (2021)

Remyelination varies between and within lesions in multiple sclerosis following bexarotene
por: Brown, J. William L., et al.
Publicado: (2022)

Bexarotene improves motor function after spinal cord injury in mice
por: Wang, Xingyu, et al.
Publicado: (2023)

Tumor immune microenvironment of cutaneous angiosarcoma with cancer testis antigens and the formation of tertiary lymphoid structures
por: Magara, Tetsuya, et al.
Publicado: (2023)

Classification and Antigen Molecules of Autoimmune Bullous Diseases
por: Hashimoto, Takashi, et al.
Publicado: (2023)

When the dust settles: what did we learn from the bexarotene discussion?
por: Tesseur, Ina, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_dj08fn0i3bgkanp0r3bnr1go4b